Physicochemical Properties
| Molecular Formula | C4H11CLN2O2 |
| Molecular Weight | 154.60 |
| Exact Mass | 154.05 |
| CAS # | 16012-55-8 |
| PubChem CID | 51358333 |
| Appearance | White to yellow solid powder |
| LogP | 0.51 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 3 |
| Heavy Atom Count | 9 |
| Complexity | 84.1 |
| Defined Atom Stereocenter Count | 1 |
| SMILES | CNC[C@@H](C(=O)O)N.Cl |
| InChi Key | VDXYGASOGLSIDM-DFWYDOINSA-N |
| InChi Code | InChI=1S/C4H10N2O2.ClH/c1-6-2-3(5)4(7)8;/h3,6H,2,5H2,1H3,(H,7,8);1H/t3-;/m0./s1 |
| Chemical Name | (2S)-2-amino-3-(methylamino)propanoic acid;hydrochloride |
| HS Tariff Code | 2934.99.9001 |
| Storage |
Powder-20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition | Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs) |
Biological Activity
| References |
[1]. The Potential Role of BMAA in Neurodegeneration. Neurotox Res. 2018 Jan; 33(1): 222-226. [2]. BMAA and Neurodegenerative Illness. Neurotox Res. 2018 Jan; 33(1): 178-183. [3]. β-N-methylamino-L-alanine (BMAA) suppresses cell cycle progression of non-neuronal cells. Sci Rep. 2018 Dec 20; 8(1): 17995. |
Solubility Data
| Solubility (In Vitro) | H2O: 31.25 mg/mL (202.13 mM) |
| Solubility (In Vivo) |
Solubility in Formulation 1: 25 mg/mL (161.71 mM) in PBS (add these co-solvents sequentially from left to right, and one by one), clear solution; with sonication.  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 6.4683 mL | 32.3415 mL | 64.6831 mL | |
| 5 mM | 1.2937 mL | 6.4683 mL | 12.9366 mL | |
| 10 mM | 0.6468 mL | 3.2342 mL | 6.4683 mL |